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ABSTRACT 
As the first line of innate immune defense, neutrophils need to mount a rapid and 
robust antimicrobial response. Recent studies implicate various positive feedback 
amplification processes in achieving that goal. Feedback amplification ensures 
effective migration of neutrophils in shallow chemotactic gradients, multiple waves of 
neutrophil recruitment to the site of inflammation, as well as the augmentation of 
various effector functions of the cells. Here, we review such positive feedback loops 
including intracellular and autocrine processes, paracrine effects mediated by lipid 
(LTB4), chemokine and cytokine mediators, and bidirectional interactions with the 
complement system and other immune and non-immune cells. Those amplification 
mechanisms are not only involved in antimicrobial immunity but also contribute to 
neutrophil-mediated tissue damage under pathological conditions.  
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OVERVIEW OF FEEDBACK AMPLIFICATION OF NEUTROPHIL FUNCTION 
Homeostatic mechanisms mostly rely on negative feedback mechanisms. 
However, rapid and robust responses to external stimuli often require positive feedback 
mechanisms. Typical examples for positive feedback include action potential, ovulation 
or blood clotting, all of which result in dramatic changes in biological processes. 
Neutrophils form the first line of innate immune defense against bacterial and 
fungal pathogens [1]. They are equipped with a multitude of cell surface receptors for 
the recognition of microbial pathogens and the inflammatory environment [2], and 
migrate to the site of inflammation through a multistep recruitment process  triggered 
by chemotactic agents including chemokines, lipid chemoattractants (primarily LTB4), 
formyl-peptides and complement fragments [3-5]. At the site of infection/inflammation, 
neutrophils use an armamentarium of effector functions, including phagocytosis, 
respiratory burst, degranulation and neutrophil extracellular trap (NET) formation to 
eliminate the invading microorganisms [6,7]. In addition, neutrophils also participate in 
the organization of the overall immune response [6-9]. Despite being short-lived, 
terminally differentiated cells with limited transcriptional activity, they can undergo 
stimulus-induced gene expression changes leading to chemokine and cytokine release 
into the extracellular space [6,10,11]. Given their robust effector functions, neutrophils 
also play a major role in tissue damage during infectious or non-infectious inflammatory 
diseases [6,12]. 
A number of recent reports indicate important roles for self-perpetuating positive 
feedback amplifications loops in promoting neutrophil recruitment and activation. Such 
feedback loops act at various levels, including amplification within single cells, 
paracrine interaction between different neutrophils, as well as more complex feedback 
loops involving other biochemical and cellular processes (Figure 1). Those 
amplification loops have likely evolved to ensure swift and robust responses against 
invading microorganisms but they also contribute to neutrophil-mediated tissue 
damage during infectious and sterile inflammatory diseases. Here we review the 
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various mechanisms of feedback amplification of neutrophil function and their 
relevance to neutrophil-mediated in vivo biological processes. Understanding feedback 
amplification of neutrophil function may facilitate the development of novel therapeutic 
strategies in diseases characterized by excessive neutrophil activation. 
 
FEEDBACK AMPLIFICATION AT THE SINGLE CELL LEVEL 
Recent reports indicate that the function of single neutrophils is amplified by 
several intracellular or autocrine feedback amplification pathways. 
 
Intracellular feedback loops promoting neutrophil polarization 
One of the most prominent biochemical features of neutrophil polarization is the 
accumulation of PtdIns(3,4,5)P3 (PIP3) at the leading edge. The cellular PIP3 gradient is 
substantially steeper than that of the extracellular chemoattractant gradient and 
exogenous PIP3 leads to the accumulation of endogenous PIP3 at the leading edge 
[13], suggesting the involvement of molecular amplification processes. 
Chemoattractant receptors trigger initial PIP3 production at the leading edge through 
PI3-kinases activated by G-protein βγ subunits (Figure 2). This initial PIP3 production 
leads to activation of Rac small GTPases, which then activate the WAVE2 complex 
scaffolded by the Hem-1 protein, eventually leading to actin polymerization and 
activation of further endogenous PI3-kinases at the leading edge [13-15]. In addition, 
Rac GTPases also activate the NADPH oxidase and reactive oxygen species (ROS) 
production at the leading edge. This results in local inhibition of PTEN, a lipid 
phosphatase responsible for the degradation of PIP3, leading to further accumulation of 
PIP3 at the leading edge [16]. Those mechanisms (Figure 2) contribute to the 
translation of a shallow extracellular gradient to robust neutrophil polarization. 
While the leading edge is characterized by Rac activation and actin 
polymerization-based protrusions, the trailing edge (uropod) is dominated by Rho 
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activation and myosin-based contraction through the Rho-activated kinase ROCK 
which phosphorylates and activates the myosin light chain MLC [5]. This differential 
signaling defines the biochemical basis of “frontness” and “backness” in polarized 
neutrophils (Figure 2). Interestingly, the two domains are mutually exclusive due to 
mutual inhibition of each other at the biochemical level [17]. Constitutive activation of 
the uropod components Rho, ROCK or MLC inhibited establishment of leading-edge 
features such as PIP3 accumulation, Rac activation or actin polymerization, while 
inhibition of the Rho/ROCK/myosin pathway had the opposite effect [17]. Furthermore, 
inhibition of “frontness” features such as actin polymerization or Gi activation [18], or by 
knockdown of the leading edge organizer Hem-1 [15], inhibited “backness” feature 
such as uropod-specific localization of Rho and phosphorylated MLC. The reciprocal 
inhibition between “frontness” and “backness” features (i. e. the inhibition of the 
inhibitors) provides an additional level of positive feedback amplification of neutrophil 
polarization and contributes to the rapid migration of neutrophils. It should be noted that 
PI3-kinase mediated cell polarization and migration is not unique to neutrophils in the 
immune system, as it also exists in T cells and macrophages [19,20]. 
 
Feedback amplification through autocrine loops 
Neutrophil migration is also promoted through autocrine feedback amplification 
loops (Fig 2). Neutrophils release ATP into the extracellular space from their leading 
edge [21] which then becomes hydrolyzed by ecto-ATPases to adenosine. ATP 
activates P2Y2 receptors at the leading edge to promote neutrophil polarization, 
whereas adenosine activates A3 receptors to promote migration of the cells along the 
chemotactic gradient [21]. Accordingly, P2Y2 and A3 receptors are required for 
effective directional migration of neutrophils both in vitro and in vivo [21]. ATP release 
also amplifies non-chemotactic functions of neutrophils through ligation of P2Y2 
receptors on the same cells [22]. Taken together, autocrine activation of purinergic 
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receptors contributes to robust neutrophil migration and activation responses, 
reminiscent of the role of IL-2 in T cell activation. 
 
Integrin-mediated adhesion as a positive feedback loop 
The majority of neutrophil functions requires adhesion to endothelial cells or 
extracellular matrix proteins through β2 integrins. Integrins are bidirectional signaling 
molecules which relay extracellular signals to the inside of the cell (“outside-in” 
signaling) but their ligand binding capacity (affinity or avidity) is also regulated by 
intracellular signals (“inside-out” signaling). Initial ligation of integrins triggers outside-in 
signals and functional responses through an immunoreceptor-like signaling pathway 
[23-31]. While integrin signaling routes mediate adhesion and/or spreading of 
neutrophils [23-27], they also trigger inside-out signaling responses under certain 
conditions [32-36]. The sequential activation of outside-in and inside-out integrin 
signaling results in feedback amplification of integrin-mediated neutrophil function. 
 
PARACRINE MECHANISMS OF FEEDBACK AMPLIFICATION 
Neutrophils have also been shown to release extracellular mediators that 
promote the function of adjacent neutrophils in a paracrine manner. Those mediators 
may either be bioactive lipids or proteinaceous (chemokine, cytokine) substances. 
 
Amplification through neutrophil-derived LTB4 
The effect of the neutrophil-derived lipid product LTB4 on other neutrophils 
provides one of the best examples of feedback amplification of neutrophil function. 
Neutrophils are the most prominent source and one of the most prominent targets of 
LTB4 [37]. LTB4 accumulates at the site of inflammation in the autoantibody-induced 
K/B×N serum-transfer arthritis model [38,39]. Mice lacking critical LTB4 synthesis 
enzymes (5-lipoxygenase or LTA4 hydrolase) or the high-affinity LTB4 receptor BLT1 
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are protected from neutrophil accumulation and development of autoantibody-induced 
arthritis [38,40,41]. Importantly, adoptive transfer of wild type neutrophils restored 
arthritis development in 5-lipoxygenase deficient (Alox5–/–) and BLT1-deficient (Ltb4r1–
/–) recipients [38,40,41], indicating that neutrophils are both a major cellular source and 
the principal target of LTB4 in this model (Figure 3). This was in line with the immune 
complex-induced in vitro release of LTB4 from neutrophils but not macrophages 
[11,39,41,42]. Further signaling studies (Figure 3B) have also revealed that the LTB4-
mediated feedback amplification of neutrophil recruitment was mediated by Src-family 
kinases, Syk, PLCγ2 and, likely, Vav-family members, but not by the CARD9 adapter 
protein [11,27,39,43,44]. 
In a laser-induced sterile dermal inflammation model, the initial accumulation of 
resident neutrophils was followed by a second, larger wave of neutrophil recruitment 
and clustering [45]. This second wave, termed neutrophil “swarming” because of its 
resemblance of the coordinated movement of insect swarms [45,46], was diminished in 
Ltb4r1–/– and Alox5–/– mice [45]. Interestingly, when wild type and Ltb4r1–/– neutrophils 
were co-injected into Alox5–/– recipients, wild type but not Ltb4r1–/– neutrophils were 
able to accumulate at the site of injury, suggesting that neutrophils release LTB4 which 
triggers recruitment of further neutrophils through BLT1 ligation [45]. Those results 
provided further evidence for LTB4-mediated amplification of neutrophil recruitment. 
LTB4-mediated amplification of neutrophil recruitment has also been reported in 
other in vivo inflammation models. Neutrophil-derived LTB4 accumulated at the 
inflammatory site in a novel model of atopic dermatitis [47]. Importantly, Ltb4r1–/– 
neutrophils were unable to accumulate at the inflammation site [47], indicating LTB4-
mediated feedback amplification also in this model (Figure 3). BLT1-dependent 
neutrophil clustering was also observed in a Pseudomonas aeruginosa infection model 
[45], and BLT1 was also required for neutrophil recruitment and antibody-mediated 
tumor immunotherapy in experimental lymphoma [48]. 
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Analysis of formyl-peptide-induced in vitro migration of neutrophils provided 
further evidence for an LTB4-mediated amplification loop [49]. Formyl peptides 
triggered chemotactic migration of wild type neutrophils but not those lacking the 
predominant formyl-peptide receptor FPR1. Inhibition of 5-lipoxygenase or genetic 
deletion of 5-lipoxygenase or BLT1 attenuated formyl-peptide-induced neutrophil 
migration [49]. Surprisingly, even Fpr1–/– neutrophils were able to migrate towards 
formyl peptides when they were mixed with wild type neutrophils. However, no 
migration of Fpr1–/– neutrophils could be observed in the presence of 5-lipoxygenase 
inhibitors or when Fpr1–/– neutrophils were mixed with Alox5–/– cells [49]. Those studies 
suggest that formyl peptides trigger a secondary gradient of LTB4 which is able to direct 
the migration of even those cells that cannot sense the primary gradient. 
Transepithelial migration of neutrophils towards Pseudomonas aeruginosa also 
required neutrophil-derived LTB4 acting through the BLT1 receptor [50]. 
Neutrophil-derived LTB4 also amplifies non-migratory functions of neutrophils. 
Immune complex stimulation triggered robust release of LTB4 from neutrophils [11,39] 
and the respiratory burst under such conditions was reduced by inhibitors of 5-
lipoxygenase or BLT1 [42]. On the other hand, inhibition of 5-lipoxygenase or BLT1 did 
not affect adhesion or spreading of formyl-peptide-stimulated neutrophils, indicating the 
specificity of the LTB4-mediated amplification loop [49]. 
A very recent report provided interesting mechanistic insight into LTB4-mediated 
feedback amplification [51]. Both LTB4 and its synthesizing enzymes 5-lipoxygenase, 
LTA4-hydrolase and FLAP were localized to multivesicular bodies and released in form 
of extracellular vesicles upon fMLP-induced neutrophil activation [51]. Exosome-
derived LTB4 acted both on the originating as well as on neighboring cells to promote 
neutrophil migration towards an fMLP source [51]. Those results extend prior reports 
[49] and suggest that LTB4 exerts its effect at least in part through neutrophil-derived 
extracellular vesicles (Figure 3). 
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In conclusion, the lipid mediator LTB4 directs neutrophils towards the site of 
inflammation and augments their cellular responses by several BLT1-dependent 
paracrine mechanisms including the potentiation of fMLP receptor signaling, 
contribution to immune complex-activation and acting of neutrophil-derived 
microvesicles on adjacent neutrophils. 
 
Amplification by neutrophil-derived chemokines 
Neutrophil-derived chemokines are also involved in paracrine amplification of 
neutrophil function (Figure 3). In the K/B×N serum-transfer arthritis model, adoptive 
transfer of wild type neutrophils into Ltb4r1–/– mice surprisingly also restored the 
recruitment of Ltb4r1–/– recipient neutrophils [40], suggesting that activated neutrophils 
are able to recruit other neutrophils through factors other than LTB4. In addition, 
germline or neutrophil-specific deletion of the CARD9 gene expression regulator 
reduced autoantibody-induced arthritis and dermatitis, along with blocking chemokine 
and cytokine but not LTB4 release from neutrophils [11]. Indeed, immune complex-
induced neutrophil activation triggered the release of a number of chemokines that are 
able to attract neutrophils, the most important of which is CXCL2 (MIP-2), but CXCL1 
(KC), and CCL3 (MIP-1α) also have effects on neutrophils [11,39,52]. While LTB4 was 
involved in the early phase of autoantibody-induced arthritis, neutrophil-derived 
chemokines promoted the recruitment of additional neutrophils during later stages of 
arthritis development as another feedback amplification process [52]. Additional 
signaling studies (Figure 3B) revealed that the chemokine-mediated feedback 
amplification of neutrophil recruitment was mediated by the CARD9 gene expression 
regulator acting downstream of Src-family kinases, Syk, PLCγ2 and, likely, Vav-family 
members [11,27,39,43,44]. 
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Other paracrine amplification mechanisms 
Neutrophils release a number of additional molecules that are able to activate 
other neutrophils in a paracrine manner (Figure 3A). Myeloperoxidase, released from 
the primary (azurophilic) granules of neutrophils, binds to neutrophil Mac-1 and 
enhances respiratory burst and granule release [53]. Myeloperoxidase also attracts 
neutrophils by promoting their adhesion to endothelial cells through electrostatic 
interactions [54]. Importantly, neither of those responses required peroxidase activity 
[53,54], indicating a non-enzymatic action of myeloperoxidase. Neutrophil activation 
also triggers release of reactive oxygen species which are thought to amplify various 
neutrophil functions through the activation of tyrosine phosphorylation pathways and, 
possibly, other mechanisms [55,56]. Neutrophils also release adenosine which may 
enhance (but may also inhibit) neutrophil functions through different adenosine 
receptors [57]. In addition, neutrophil-derived TNF-α has been shown to contribute to 
the amplification of IL-6 production by human neutrophils stimulated by a TLR8 ligand 
[58]. 
The MRP8/14 (S100A8/9) proteins are the most abundant cytosolic proteins in 
neutrophils and are released into the extracellular space upon neutrophil activation 
[59]. Importantly, MRP8/14 has been shown to promote neutrophil adhesion and, 
possibly, other neutrophil functions [60,61]. A recent report also revealed that MRP8/14 
is released upon neutrophil rolling on E-selectin-coated endothelial surfaces and then 
promotes rapid activation of β2 integrin-mediated neutrophil adhesion by binding to the 
TLR4 receptor [62], contributing to the amplification of neutrophil recruitment. 
Taken together, several paracrine mechanisms contribute to positive feedback 
loops of neutrophils, including the lipid mediator LTB4, chemokines, the granule 
component myeloperoxidase or MRP8. Those mediators act on different receptors 
including the LTB4 receptor BLT1, G protein-coupled chemokine receptors, as well as 
integrins and Toll-like receptors.  
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COMPLEX FEEDBACK AMPLIFICATION LOOPS 
Neutrophils are also involved in more complex feedback amplification loops 
involving complex biochemical pathways or interaction with other cell types. 
 
Amplification of neutrophil function through complement activation 
The complement system interacts with neutrophils in a bidirectional manner. 
While neutrophils are capable of promoting complement activation, end products of 
complement activation such as C5a, a major neutrophil chemoattractant, and C3b, a 
ligand of the β2-integrin Mac-1, also strongly stimulate neutrophils (Figure 4A). 
The alternative pathway of complement activation mediates autoantibody-
induced arthritis through the action of complement-derived C5a on C5a-receptors on 
neutrophils [41,63,64]. C5a is able to promote LTB4 production by neutrophils [41] and 
mixed bone marrow chimeric and adoptive neutrophil transfer experiments revealed 
that C5a-receptors and 5-lipoxygenase had to be present on the same individual 
neutrophils [41]. Those results suggest that neutrophils act downstream of complement 
activation through C5a-mediated LTB4 production. However, several lines of evidence 
suggest that neutrophils are also required for complement activation in this model. In 
the affected joints, neutrophils but not C3 or C5a-receptors were required for the initial 
vascular permeability increase [65] and neutrophils but not C5 were required for the 
initial accumulation of pathogenic anti-GPI antibodies [66]. Both those initial responses 
also required the Fc-receptor γ-chain which is thought to be primarily involved in 
neutrophil activation in this model [64-66]. Autoantibody-induced accumulation of 
C5/C5a was also abrogated in mice lacking the myeloid-specific Src-family kinases 
Hck, Fgr and Lyn which likely mediate neutrophil activation in this model [39]. Those 
results together suggest complement-mediated amplification of neutrophil function in 
autoantibody-induced arthritis and, possibly, in other autoantibody-mediated (e. g. 
glomerulonephritis, vasculitis, dermatitis) diseases (Figure 4A). 
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In vitro studies also confirmed the complement-mediated feedback amplification 
of neutrophil function. Supernatants of neutrophils activated by anti-neutrophil 
cytoplasmic antibodies triggered complement activation and C5a generation [67,68]. 
Such conditioned supernatants were then able to prime neutrophils for respiratory burst 
in a C5a-receptor-dependent manner, indicating existence of a feedback amplification 
loop [68]. Neutrophil activation by various stimuli also triggered the alternative pathway 
of complement activation which in turn resulted in neutrophil activation primarily 
through C5a generation [69]. 
The mechanism of neutrophil-mediated complement activation is still 
incompletely understood. While prior studies suggested a role for reactive oxygen 
species and granule enzymes such as myeloperoxidase and neutrophil-derived 
proteases [67], those assumptions could not be confirmed by a more recent study [69]. 
On the other hand, activated neutrophils have been shown to release properdin, a 
positive regulator of the alternative complement pathway [69,70]. Together with the role 
of properdin expressed in a myeloid-lineage cell in the development of the K/B×N 
serum-transfer arthritis [71], those results suggest amplification of neutrophil function 
through complement activation triggered by neutrophil-derived properdin (Figure 4A). 
Taken together, the activation of the complement system is a critical feedback 
amplification mechanism of neutrophil function since the cascade can be initiated by 
neutrophils and its products (C5a and C3b) also act on neutrophils themselves, either 
as chemoattractants or activators of the cells. 
 
Amplification by granule proteases 
Neutrophils contain several granule proteins, including proteolytic enzymes such 
as the matrix metalloprotease gelatinase B (MMP9) or neutrophil elastase that are 
released upon cellular activation. In line with the role of matrix metalloproteases in 
processing various chemokines and cytokines [72], gelatinase B is able to cleave 
CXCL8/IL-8, strongly increasing its potency to further activate neutrophils [73]. 
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Gelatinase B also triggers the generation of Pro-Gly-Pro (PGP) peptide fragments from 
extracellular matrix proteins that attract and activate neutrophils through CXCR1/2 
during airway inflammation (Figure 4B) [74,75]. Neutrophil proteases have also been 
found to self-perpetuate the pathogenesis of experimental bullous pemphigoid: upon 
neutrophil activation, gelatinase B is released and activates neutrophil elastase by 
cleaving its natural inhibitor α1 proteinase inhibitor; elastase then digests BP180, 
generating fragments with direct chemotactic activity on other neutrophils [76-78]. 
Taken together, granule proteases are not only important components of 
antimicrobial activity, but they also actively participate in augmenting neutrophil 
functions by increasing the potency of neutrophil-active chemokines or generating 
chemoattractants from extracellular proteins. 
 
Amplification of neutrophil function through other immune cells 
Neutrophils participate in bidirectional interactions with other immune cells [79]. 
Neutrophils can recruit and activate inflammatory monocytes/macrophages and vice 
versa. Both neutrophils and monocytes/macrophages can produce several chemokines 
like CXCL1, CXCL2, CXCL8, CCL2, CCL3 and CCL4 chemokines besides expressing 
their receptors [80]. Furthermore, neutrophil granule components like cathepsin G or 
azurocidin also attract monocytes [81]. Azurocidin exerts its recruitment effect directly 
through β2 integrins or indirectly through endothelial cells and activates macrophages 
to release neutrophil degranulating cytokines, completing a feedback amplification loop 
[82] (Figure 4C). Activated macrophages can also release matrix metalloproteinases 
[83] such as MMP8 and MMP9, which promote neutrophil chemotaxis by proteolytic 
activation of CXCL5 and CXCL8 [73,84]. Moreover, macrophages, in concert with 
TNFα, can trigger CCL2 (MCP-1) release from neutrophils and promote their own 
recruitment [85]. Further details of the interaction of neutrophils and 
monocytes/macrophages can be found in refs. [80,86]. 
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Th17 cells are crucial in antifungal host defense and in various autoimmune 
diseases. A recent study showed that neutrophils stimulated by IFNγ and LPS release 
Th17 cell-attracting CCL2 and CCL20 chemokines, while activated Th17 cells produce 
the neutrophil chemoattractant CXCL8 [87] (Figure 4C). In line with this bidirectional 
recruitment effect, both neutrophils and Th17 cells were found in the synovial fluid of 
patients with rheumatoid arthritis and in gut samples from people with Crohn’s disease 
[87]. Moreover, Th17 cells promote granulopoiesis via the release of G-CSF from 
tissue fibroblasts and can delay neutrophil apoptosis through the production of GM-
CSF, TNFα and IFNγ [87,88]. 
The pathogenesis of atherosclerosis serves as an example for a complex 
amplification loop between neutrophils, macrophages and Th17 cells. Cholesterol 
crystals, which are typical constituents of advanced atherosclerotic plaques, can trigger 
macrophage IL-1β and IL-6 production through NET formation, leading to the release of 
IL-17 from Th17 cells. IL-17 then triggers the release of neutrophil chemoattractants (e. 
g. CXCL2), resulting in the amplification of neutrophil recruitment and atherosclerosis 
progression in mice [89]. However, some authors argue against the importance of NET 
formation in the development of atherosclerosis, pointing to other potential neutrophil-
mediated mechanisms [90]. 
Certain bacterial antigens can trigger neutrophils to produce mature IL-18 that 
promotes the release of IFNγ from NK cells in the presence of dendritic cell-derived IL-
12 [91]. IL-18-activated NK cells can prolong neutrophil survival through the production 
of GM-CSF and IFNγ [92]. For further cooperative amplification loops between 
neutrophils and T cells or NK cells, we refer to previous review articles [79,93]. 
 
The role of platelets and stromal cells in the amplification of neutrophil function 
Endothelium-attached activated platelets initiate a neutrophil-platelet interaction 
mainly through PSGL-1–P-selectin and LFA-1–ICAM-2 interactions promoting 
neutrophil extravasation [94]. Activated platelets also release CXCL4 and CCL5 from 
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their α-granules that promote neutrophil accumulation in septic lungs in the coecal 
ligation and puncture model through the release of CXCL2 from alveolar macrophages 
[95,96]. On the other hand, neutrophil-derived cathepsin G can trigger platelet 
activation through the protease-activated receptor 4 (PAR4) and mediate intracellular 
calcium signaling [97]. Moreover, cathepsin G can cause platelet aggregation [98]. In 
the presence of LPS, platelets provoke NET formation, which activates the coagulation 
cascade with an increase in the local platelet-activating thrombin concentration [99]. 
Moreover, NETs can directly activate platelets [99] (Figure 4D). For further information, 
we refer to previous review articles [100,101]. 
 In experimental arthritis, immune complex-activated neutrophils undergo gene 
expression changes and produce interleukin-1β that provokes resident synovial tissue 
cells like fibroblast-like synoviocytes to produce neutrophil attracting chemokines 
[52,64]. Fibroblast-like synoviocytes mainly attract neutrophils by producing CXCL5, 
CXCL1 and CXCL2  [52] (Figure 4E). 
There are several ways for endothelial cells to activate neutrophils and vice 
versa. Activated endothelial cells promote mobilization of neutrophils from the bone 
marrow through G-CSF, recruit them by chemokines (e.g. by CXCL1 and CXCL2), and 
participate in neutrophil extravasation; inflammatory neutrophils in turn produce 
cytokines (e.g. IL-1β, TNFα) that activate the vascular endothelium [52,102] (Figure 
4E). 
Danger-associated molecular patterns (DAMPs) such as ATP or uric acid can be 
released from dying stromal cells and can trigger neutrophil migration/activation [103]. 
As neutrophil influx often causes tissue injury, it is probable that necrosis-inducing 
neutrophils support their own recruitment and/or activation through these molecules. 
In conclusion, platelets and different types of stromal cells act in concert to trigger 
amplification of neutrophil activation and enhance their effector functions. 
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Additional complex amplification of neutrophil function  
The pathogenesis of systemic lupus erythematosus is a typical example for a 
feedback amplification involving neutrophils and dendritic cells. DNA‒anti-DNA immune 
complexes trigger the release of NETs, increasing the amount of extracellular DNA 
molecules [104,105]. This process is amplified by immune complexes containing 
neutrophil-derived DNA decorated with the antimicrobial peptide LL37, which activates 
plasmacytoid dendritic cells to release interferon-α (IFNα); IFNα then facilitates NET 
formation, amplifying the initial disease process (Figure 4F) [104,105]. 
In small vessel vasculitis, anti-neutrophil cytoplasmic antibodies (ANCA) can 
trigger the release of the B cell survival factor B Lymphocyte Stimulator (BLyS) from 
neutrophils, which, besides serving as a survival signal, helps the differentiation of B 
cells into ANCA-producing plasma cells [106]. These pathological anti-neutrophil 
cytoplasmic antibodies (ANCA) targeting myeloperoxidase or proteinase 3 can then 
trigger NET formation, which results in the release of further myeloperoxidase and 
proteinase 3 autoantigens (Figure 4F) [107]. 
Similar to ANCA, anti-citrullinated protein antibodies (ACPA) found in the most 
progressive forms of rheumatoid arthritis has been shown to provoke neutrophil NET 
formation, leading to release of citrullinated autoantigens and generation of further 
ACPA-containing immune complexes (Figure 4F) [108]. Furthermore, these NETs 
could induce CXCL8 release from synovial fibroblasts [108].  
In summary, positive neutrophil amplification loops also seem to be crucial 
components of human autoimmune disorders. 
 
CONCLUSION 
The feedback amplification mechanisms discussed above are well suited to 
promote a rapid and robust neutrophil response during the early phases of microbial 
invasion. Feedback amplification may enhance neutrophil function at several different 
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levels. It may promote sensing and responding to minute changes and small gradients 
in the extracellular environment and it may augment the response of neutrophils by 
increasing the speed, amplitude and range of the response. At the cellular level, 
positive feedback triggers the self-organization of cellular responses such as 
polarization or lamellipodium formation. 
A typical feature of feedback amplification is that the entire process is abrogated 
irrespective of where the loop is broken, providing an opportunity for therapeutic 
intervention (see Outstanding Questions). However, this also often conceals exact 
molecular mechanisms and hierarchies between the components involved. Given the 
strong feedback amplification of neutrophil function, one would expect that terminating 
the inflammation process would also require active mechanisms. Indeed, the last 
several years have revealed that termination of inflammation is governed by an active 
process called resolution of inflammation, coordinated by specialized pro-resolving lipid 
mediators [109]. 
Besides understanding the overall mechanisms of feedback amplification of 
neutrophil function, several reports have also contributed to understanding the 
signaling details involved in an in vivo inflammatory environment. We and others have 
shown that a tyrosine kinase signaling pathway involving Src-family kinases, Syk, 
PLCγ2 and CARD9 plays a critical role in neutrophil-mediated inflammatory reactions 
and proposed that they are primarily involved in triggering processes that amplify 
neutrophil function through the generation of extracellular inflammatory mediators 
[11,27,39,43,44,110]. Components of that pathway may become therapeutic targets of 
inflammatory diseases involving a robust neutrophil response [12]. 
Though feedback amplification is likely critical for the swift and robust responses 
of neutrophils to invading microorganisms, it also contributes to neutrophil-mediated 
tissue damage. Understanding feedback amplification processes may therefore provide 
better understanding and possibly novel therapeutic targets of diseases characterized 
by a significant neutrophil-mediated inflammatory component. 
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FIGURE LEGENDS 
Figure 1 
Overview of neutrophil amplification mechanisms 
Activated neutrophils can directly enhance their own activity/migration through 
autocrine and paracrine routes. In addition, they can promote their own functions by 
modifying the activation state of the complement system, the release of various granule 
proteases, the formation of neutrophil extracellular traps or influencing the activity of 
other immune/non-immune cells. Abbreviations: PMN, Polymorphonuclear cell 
(neutrophil); NETs, Neutrophil extracellular traps. 
 
Figure 2 
Intracellular and autocrine feedback amplification loops of neutrophil function 
Neutrophils become polarized upon sensing the chemotactic gradient by forming a 
leading and a trailing edge. The leading edge is characterized by “frontness” features 
including a massive PIP3 accumulation through the activation of PI3-kinases (PI3K). 
This leads to actin polymerization by Rac and activation of further PI3K molecules. 
Activated Rac also promotes the function of the NADPH oxidase and reactive oxygen 
species production, resulting in the inhibition of the PIP3-degrading PTEN. Meanwhile, 
the trailing edge is characterized by “backness” features such as Rho activation and 
myosin-based contraction. Interestingly, there is a reciprocal inhibition between the 
“frontness” and “backness” features, amplifying the polarization process. In addition, 
ATP and its metabolite adenosine further amplifies neutrophil polarization/migration in 
an autocrine manner. Abbreviations: PIP3, Phosphatidylinositol(3,4,5)-trisphosphate; 
PI3K, Phosphatidylinositol 3-kinase; PTEN, Phosphatase and tensin homolog; ROCK, 
Rho-associated protein kinase; ROS, Reactive oxygen species; PMN, 
Polymorphonuclear cell (neutrophil). 
 
Figure 3 
Paracrine neutrophil amplification circuits 
(A) Neutrophils reciprocally interact with other neutrophils by producing the lipid 
mediator LTB4, through chemokines such as CXCL1, CXCL2 and CCL3, by releasing 
myeloperoxidase from intracellular granules, or through the release of MRP8/14. (B) 
Paracrine mechanisms through neutrophil-derived LTB4, chemokines and cytokines 
lead to feedback amplification of neutrophil recruitment from the vascular space. 
Release of all those mediators requires Src-family kinases, Syk PLCγ2 and Vav-family 
members, whereas chemokine/cytokine but not LTB4 release is mediated by CARD9. 
LTB4, Leukotriene B4; MPO, Myeloperoxidase; TLR4, Toll-like receptor 4; Mac-1, 
Macrophage-1 antigen (CD11b/CD18); PMN, Polymorphonuclear cell (neutrophil).  
 
Figure 4 
Complex feedback amplification loops 
(A) Neutrophils activate the complement system by various routes. Activated 
complement fragments such as C5a or C3b further enhance neutrophil 
activation/recruitment. (B) Neutrophil granule proteases cleave chemokines and 
extracellular matrix proteins, resulting in emergence of even more potent 
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chemoattractants. (C) Neutrophils promote their own recruitment/activation by the 
release of different granule molecules and chemokines, which trigger the release of 
neutrophil-acting chemokines from macrophages and Th17 cells. (D) Neutrophils 
activate platelets by granule proteins or NET formation, while platelets enhance 
neutrophil accumulation by direct interaction or chemokine release. (E) Neutrophils 
bidirectionally interact with fibroblasts and endothelial cells through different cytokines 
and chemokines. (F) NET formation results in the release of various autoantigens that 
trigger further autoantibody production and NET release. Abbreviations: PMN, 
Polymorphonuclear cell (neutrophil); Mac-1, Macrophage-1 antigen (CD11b/CD18); 
MMP9, Matrix metalloproteinase 9; ECM, Extracellular matrix; PGP, Proline-Glycine-
Proline peptide fragments; MΦ, Macrophage; Th17, Th17 cells; NETs, Neutrophil 
extracellular traps; PSGL-1, P-selectin glycoprotein ligand-1; ANCA, Anti-neutrophil 
cytoplasmic antibody; ACPA, Anti-citrullinated protein antibody; FcR, Fc receptor. 
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